Fen Lai Tan
Directeur/Bestuurslid bij Capio Biosciences, Inc.
Profiel
Fen Lai Tan is currently a Director at Capio Biosciences, Inc. Prior to this, he worked as a Director, Chief Medical Officer & Senior VP at Betta Pharmaceuticals Co., Ltd.
from 2013 to 2018.
Dr. Tan holds a doctorate degree from The University of Arkansas.
Actieve functies van Fen Lai Tan
Bedrijven | Functie | Begin |
---|---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Fen Lai Tan
Bedrijven | Functie | Einde |
---|---|---|
BETTA PHARMACEUTICALS CO., LTD. | Hoofd Techniek/Wetenschap/O&O | 26-03-2018 |
Opleiding van Fen Lai Tan
The University of Arkansas | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Health Technology |